ERYTECH Provides Business Update and Financial Highlights for Q1 2017 Post author:admERY Post published:May 18, 2017 Post category:Newsroom ERYTECH today provided a financial and business update for the first quarter of 2017 ended March 31, 2017. You Might Also Like ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019 ERYTECH reports positive top-line Phase III results from clinical study with GRASPA® in Acute Lymphoblastic Leukemia September 30, 2014 ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting December 7, 2020
ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019
ERYTECH reports positive top-line Phase III results from clinical study with GRASPA® in Acute Lymphoblastic Leukemia September 30, 2014
ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting December 7, 2020
